Details for Patent: 7,887,844
✉ Email this page to a colleague
Summary for Patent: 7,887,844
| Title: | Multiparticulate crystalline drug compositions having controlled release profiles |
| Abstract: | A multiparticulate for controlled release of a drug comprises crystalline drug, a glyceride having at least one alkylate substituent of at least 16 carbon atoms, and a poloxamer, wherein at least 70 wt % of the drug in the multiparticulate is crystalline. |
| Inventor(s): | Leah E. Appel, Roderick J. Ray, David K. Lyon, James B. West, Scott B. McCray, Marshall D. Crew, Dwayne T. Friesen, Scott M. Herbig, Julian B. Lo |
| Assignee: | Pfizer Corp SRL |
| Application Number: | US11/004,168 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Process; |
Drugs Protected by US Patent 7,887,844
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,887,844
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2005053652 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
